About Us
Who we are
At Galen Health, we're transforming the future of pancreatic cancer care through innovative artificial intelligence technology for early detection. Our mission is to dramatically improve survival rates by identifying at-risk patients earlier, when treatment can make the greatest difference.
The Problem We’re Solving
Pancreatic cancer is one of medicine's most formidable challenges. Often called a "silent killer," this devastating disease typically presents no symptoms until it has reached advanced stages, when treatment options are limited and outcomes are poor. By the time most cases are diagnosed, the cancer has already spread, leading to five-year survival rates of just 3% for late-stage patients.
But there's hope. When pancreatic cancer is caught early, survival rates increase more than tenfold. The challenge lies in identifying who is at risk and needs screening before symptoms appear.
Our Innovation
Galen Health is pioneering a revolutionary approach to this challenge. OncoSight, our AI-powered early detection platform, analyzes electronic health records to identify subtle patterns and risk factors that might escape human detection. It continuously monitors patient data to flag individuals who may benefit from early screening, enabling healthcare providers to take proactive action.
This precision approach to screening means:
Higher-risk patients can be identified before symptoms develop
Healthcare resources can be directed where they're needed most
More cases can be caught at early, treatable stages
Lives can be saved through timely intervention
Why It Matters
Every year, thousands of families face the devastating impact of late-stage pancreatic cancer diagnoses. Each day 137 lives are lost to this terrible disease. By shifting detection earlier, we're not just improving survival statistics – we're giving people more years with their loved ones and a better opportunity for successful treatment. We are tackling the most meaningful challenge we know of.
Our work represents a fundamental shift from reactive to proactive healthcare. By harnessing the power of AI and existing health data, we're making early detection accessible and practical in ways never before possible.
Join Us in Making a Difference
We believe technology can and should serve humanity's most pressing healthcare challenges. At Galen Health, we're committed to turning this belief into reality, one patient at a time. Together with healthcare providers and partner institutions, we're working toward a future where pancreatic cancer no longer claims lives simply because it wasn't caught in time.
Learn more about partnering with Galen Health or contact us to discover how we can work together to save lives through early detection.
Getting Started
Schedule a free consultation to discuss which offering best fits your organization's needs.
All services include:
Expert-led delivery
Comprehensive documentation
Implementation support
ROI analysis
HIPAA-compliant methodology
Other ways to make a difference
Make an impact today
Pancreatic cancer is often diagnosed too late. We're developing AI technology to detect it earlier, when treatment is most effective. Help fund critical research and development that could save thousands of lives.
Every month of earlier detection can increase survival rates by 10-20%. Your support helps.
Note: As we are a for-profit company developing healthcare technology, contributions are not tax-deductible. Your support directly funds our research and development efforts.